HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading  by Peh, Chen Au et al.
Immunity, Vol. 8, 531±542, May, 1998, Copyright 1998 by Cell Press
HLA-B27±Restricted Antigen Presentation
in the Absence of Tapasin Reveals Polymorphism
in Mechanisms of HLA Class I Peptide Loading
1993). Antigenic peptides derived from degraded pro-
teins in the cytoplasm are conveyed into the endoplas-
mic reticulum (ER) by transporters associated with anti-
gen processing (TAP) (Howard, 1995). The acquisition
of suitable peptides by class I/b2-microglobulin (b2m)
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specific immunity. Thus HLA-B53 is associated with
Summary protection against cerebral malaria in West Africa (Hill et
al., 1992), whereas HLA-B*2701, B*2702, B*2704, B*2705,
Tapasin is a resident ER protein believed to be critical and B*2707 all confer dramatically increased suscepti-
for antigen presentation by HLA class I molecules. bility to ankylosing spondylitis and related inflammatory
We demonstrate that allelic variation in MHC class I spondyloarthropathies (Khan, 1995). Not all polymor-
molecules influences their dependence on tapasin for phism in MHC molecules is directly related to the speci-
peptide loading and antigen presentation. HLA-B*2705 ficity of the antigen-binding cleft, raising the possibility
molecules achieve high levels of surface expression that other structural properties of class I molecules,
and present specific viral peptides in the absence of particularly allelic families like B27, might influence their
tapasin. In contrast, HLA-B*4402 molecules are highly function in immune responses. For instance, HLA-Aw68
dependent upon human tapasin for these functions, does not interact efficiently with CD8 as a result of a
while HLA-B8 molecules are intermediate in this regard. mutation in its a3 domain (Salter et al., 1989). In TAP-
Significantly, HLA-B*2705 like HLA-B*4402, requires mutant cell lines, HLA-A2 can be expressed stably at
tapasin to associate efficiently with TAP (transporters the cell surface because this allele is adept at capturing
associated with antigen processing). The unusual abil- peptidesderived from TAP-independent signal sequences
ity of HLA-B*2705 to form peptide complexes without (Henderson et al., 1992; Wei and Cresswell, 1992).
associating with TAP or tapasin confers flexibility in There are some reported differences in the molecular
the repertoire of peptides presented by this molecule. interactions of MHC class I molecules during antigen
We speculate that these properties might contribute presentation but their significance is unclear. Thus, TAP
to the role of HLA-B27 in conferring susceptibility to binding is reported to vary between different HLA class
inflammatory spondyloarthropathies. I molecules (Neisig et al., 1996) but interpretation of
the data is complicated by limitations of the assay for
TAP±class Iassociation. Similarly, there issome sugges-Introduction
tion that surface expression of HLA class I molecules
displays allelic variation in the level of tapasin depen-Class I molecules of the major histocompatibility com-
dence (Greenwood et al., 1994), even though recentplex (MHC)are highly polymorphic cell surface glycopro-
studies imply a critical role for tapasin in this functionteins that present peptide antigens of eight to ten amino
and for presentation of specific antigens by HLA classacid residues to cytotoxic T cells (Rammensee et al.,
I molecules (Grandea et al., 1995, 1997; Ortmann et al.,
1997). In this study we have evaluated allelic differences
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HLA-B alleles for efficient surface expression and anti-
gen presentation inmouse cells and in tapasin-defective
human lymphoblastoid cells. The data reveal that HLA-
B*4402 is highly dependent upon tapasin expression for
proper cell surface expression and antigen presentation
whereas HLA-B*2705 can perform these functions al-
most normally in the absence of tapasin. This property
of B*2705 may underlie its well-known association with
susceptiblity to spondyloarthropathy.
Results
Polymorphism in the Level of Cell Surface
Expression of HLA Class I Molecules
by Murine Cells
We have previously exploited the possibility of molecu-
lar incompatibilities across species barriers to elucidate
critical steps in antigen presentation (Brooks et al.,
1994). We therefore examined the cell surface expres-
sion of HLA-B*4402 (B*4402), HLA-B*2705 (B*2705), and
HLA-B8 (B8) in transfected murine L cells coexpressing
human b2m (J26). We were surprised at the marked dif-
ferences in surface expression of B*4402, B*2705 and
B8 in transfected J26 mouse cells despite the coex-
pression of human b2m. A spectrum of HLA class I sur-
face expression was consistently evident in pools of
transfected cells (Figure 1A), with high levels of surface
B*2705 expression (peak channel fluorescence 2500)
and more than 10-fold lower surface levels of B*4402
expression (pcf 5 170). Surface B8 levels (pcf 5 600)
were between those of B*2705 and B*4402. In contrast
to the low surface level of B*4402 expressed in murine
cells, this molecule was expressed normally in human
Jurkat cells transfected with the identical gene con-
struct. In addition, immunoprecipitation of newly synthe-
sized free HLA heavy chains revealed that essentially
similar levels of B*4402 and B*2705 were translated in
these transfectants indicating a posttranslational reason
for the differences in their surface expression (data not
shown).
Failure to load MHC class I molecules with peptide
antigen in TAP-defective cell lines results in expression
of class I molecules that are thermolabile at 378C but
that can be stabilized in cells cultured at 268C overnight
(Ljunggren et al., 1990). Therefore, we compared the
surface expression of HLA class I molecules by J26
transfectants that have been incubated overnight at ei-
ther 378C or 268C (Figure 1A). Significant restoration of
Figure 1. Polymorphism in the Expression Level and Maturation Ki-surface class I expression was evident at 268C for
netics of Cell Surface HLA Class I Molecules Expressed in MurineB*4402 (8-fold) and to a lesser extent for B8 (3-fold). Cells
Enhancement of surface B*2705 expression was mar- (A) Mouse L cells expressing human b2m (J26) were transfected with
ginal following culture at 268C. These findings suggested DNA encoding the heavy chains of either HLA B*2705, B8, or B*4402
and stainedby indirect immunofluorescence using mAb W6/32 (anti-impaired intracellular peptide loading of B*4402 and B8
HLA class I). FACS histograms are shown for cells cultured at 378Cmolecules in mouse cells that was partially reversible
(dotted lines) and 268C (solid lines). Jurkat cells were transfected
by thermostabilization of molecules at 268C. with DNA encoding HLA B*4402 (bottom) and stained with 116.5.28
antibody (anti-Bw4). Staining of untransfected J26 or Jurkat cells is
shown in the filled histograms.
Impaired Intracellular Transport of (B) The indicated cells were pulsed labeled with [35S]methionine for
HLA-B*4402/Human b2m Molecules 5 min and chased in excess cold methionine for 30, 60, or 90 min.
Labeled B*4402 and B*2705 heavy chains were recovered, and ain Mouse Cell Transfectants
sample from each time point was either digested with endoglycosi-HLA class I heavy chains that cannot form stable MHC
dase-H (1) or mock digested (2) overnight. Proteins were separated
complexes mature slowly and are inefficiently trans- by SDS-PAGE in a 10% gel. Endoglycosidase-H±sensitive (S) and
±resistant (R) protein bands are indicated by arrowheads.ported to the cell surface resulting in their premature
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degradation (Ljunggren et al., 1990; Hughes et al., 1997).
Therefore, we compared the intracellular maturation and
transport of newly synthesized B*4402 with B*2705 mol-
ecules expressed in mouse J26 cells and with B*4402
molecules expressed in human Jurkat cells. In a pulse-
chase experiment (Figure 1B), the majority of B*4402
heavy chains in J26 cells remained sensitive to endogly-
cosidase-H digestion even after 90 min, whereas the
majority of B*2705 heavy chains had become resistant
by this time indicating their egress from the ER with the
acquisition of a mature carbohydrate phenotype. The
majority of B*4402 heavy chains in Jurkat cells were
endoglycosidase-H resistant, consistent with their effi-
cient expression on human cells. The impaired matura-
tion of B*4402 complexes in murine cells is consistent
with the inability of the human B*4402 heavy chain to
form stable HLA±peptide complexes in the murine cellu-
lar microenvironment.
Human TAP1 and TAP2 Fail to Restore Proper
Surface Expression of HLA-B*4402
in Murine J26 Cells
Murine TAP molecules are known to be less promiscu-
ous than human TAP molecules in the specificity of
peptides translocated from the cytosol into the ER
(Momburg et al., 1994), raising the possibilities that
mouse TAP either deliveredpeptides of unsuitablespec-
ificity for B*4402 or interacted poorly with this HLA allele
in the loading of peptides. Therefore, we transfected
human TAP1 (hTAP1) and TAP2 (hTAP2) genes into J26
cellsexpressing B*4402. Cell surface expression of HLA-
B*4402 was unchanged in the presence of hTAP1 alone,
hTAP2 alone, or hTAP1/hTAP2 (data not shown), even
though their expression was confirmed by Western blot
analysis (data not shown). Thus, impaired peptide load-
ing of B*4402 molecules in mouse cells was unlikely to
be the result of a species incompatibility between this
HLA allele and mouse TAPs. Nonetheless this experi-
ment did not rule out species incompatiblity with other Figure 2. Introduction of the Human Tapasin Gene Restores Effi-
componentsof theantigen presentation machinery such cient Maturation, Transport, and Surface Expression of HLA Class
as calnexin, calreticulin, or tapasin. The intact expres- I Molecules in Mouse Cells
sion of class I molecules by calnexin deficient cells (Sa- (A) J26 cells expressing HLA B*2705, B8, or B*4402 were transfected
with the human tapasin gene and stained by indirect immunofluores-dasivan et al., 1995; Scott and Dawson, 1995) and the
cence with mAb W6/32 after incubation at 378C. Flow cytometrichigh degree of conservation between mouse and human
histograms of the tapasin-negative (dotted lines) and tapasin-posi-calreticulin molecules (.95%) implied that failure of
tive cells (solid lines) are shown. Staining of untransfected J26 cells
these molecules to function across species was unlikely. is shown in the filled histograms. The increment in surface HLA
Therefore, we studied the possibility that HLA-B*4402 expression following tapasin transfection was calculated from peak
required human tapasin for proper surface expression channel fluorescence values and indicated for each of the paired
histograms.in mouse cells.
(B) J26 cells expressing HLA B*4402 in the absence (J26.B4402) or
presence (J26.B4402.hTapasin) of human tapasin were pulse la-
Transfection of the Human Tapasin Gene beled with [35S]methionine for 5 min. HLA complexes were immuno-
precipitated with mAb W6/32, dissociated in SDS buffer, and di-Fully Restores Surface Expression
gested either with endoglycosidase-H (1) or mock digested (2)of B*4402 on Murine J26 Cells
overnight. The digested proteins were separated by 10% SDS-PAGETo assess the effect of human tapasin on HLA expres-
and autoradiographed after fluorography. Chase times are indi-
sion in mouse cells, a human tapasin cDNA was cotrans- cated, and endoglycosidase-H±sensitive (S) and resistant (R) protein
fected with genes encoding either B*4402, B8, or B*2705 bands are indicated by arrowheads.
into J26 murine cells. Human tapasin fully restored the
surface expression of B*4402 and B8 in J26 cells at 378C
(Figure 2A). The enhancement in surface expression of Since mouse cells express endogenous tapasin (B. Ort-
mann, personal communication, and data not shown),B*4402 (20-fold) and B8 (5-fold) in the presence of hu-
man tapasin was much greater than the enhancement these findings suggested that murine tapasin could not
substitute for human tapasin in the assembly of B*4402in levels of B*2705 (2-fold) under the same conditions.
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molecules but might function in the peptide loading of
B8 and B*2705 molecules.
Human Tapasin Rescues B*4402 from Intracellular
Degradation While Promoting Its Maturation
and Transport in Murine Cells
Since human tapasin fully restored the cell surface ex-
pression of B*4402 in murine J26 cells, we examined
the effect of human tapasin on the maturation and intra-
cellular transport of B*4402 molecules. J26 cells ex-
pressing B*4402 in the presence or absence of human
tapasin were pulse-chased with [35S]methionine and
B*4402 heavy chains were immunoprecipitated (Figure
2B). After 105 min chase, B*4402 heavy chains were
efficiently recovered, and the majority were mature (en-
doglycosidase-H resistant) in the presence of human
tapasin but remained immature (endoglycosidase-H sen-
sitive) in its absence. The poor recovery of B*4402 heavy
chains at 105 min in the absence of human tapasin
indicates probable degradation of B*4402 complexes
consistent with defective peptide loading. Therefore,
human tapasin not only promoted the maturation and
transport of B*4402 molecules in murine cells; it also
rescued them from intracellular degradation.
HLA Class I Molecules Show a Spectrum
of Dependence on Human Tapasin for
Figure 3. HLA Class I Molecules Show a Spectrum of Tapasin De-Surface Expression in a Tapasin-Deficient
pendence for Efficient Surface Expression in Human Cells
Human Cell Line
Transfected tapasin-defective 721.220 cells expressing either HLA
The demonstration of HLA polymorphism in the require- B*2705, B8, or B*4402 were cotransfected with a human tapasin
ment for human tapasin to achieve full surface expres- cDNA. Stable transfectants either expressing (solid lines) or lacking
(dotted lines) human tapasin were stained by indirect immunofluo-sion of HLA class I molecules in murine cells was con-
rescence with mAb 116.5.28 (anti-Bw4) to detect B*2705 and B*4402founded by the presence of murine tapasin in these
expression or with mAb 126.39 (anti-Bw6) to detect B8 expression.cells. Therefore, we examined the expression of B*2705,
All cells were incubated at 378C. Staining of untransfected 721.220
B8, and B*4402 in the human cell line 721.220, known cells is shown by the filled histograms. The increment in surface
to be deficient in the expression of tapasin (Greenwood HLA expression following tapasin transfection was calculated from
et al., 1994; Grandea et al., 1995). The 721.220 cell line peak channel fluorescence values and indicated for each of the
paired histograms.was cotransfected with the genes encoding either
B*2705, B8, or B*4402 heavy chains with and without
the human tapasin gene. Pooled transfectants were then Tapasin Expression Greatly Enhances the
analyzed for surface expression of these HLA molecules Association of HLA B*2705 and B*4402
at 378C (Figure 3). Molecules with TAP
The data in 721.220 transfectants were very similar The physical colocalization of TAP with newly synthe-
to that obtained in the J26 mouse cell transfectants. sized MHC class I molecules might facilitate rapid pep-
Whereas B*4402 was significantly dependent on tapasin tide loading of empty class I/b2m complexes (Ortmann
for surface expression, the steady-state levels of B*2705 et al., 1994; Suh et al., 1994). Tapasin is known to pro-
were similar regardless of whether tapasin was present mote this process perhaps by bridging TAP to empty
or not. Intermediate levels of B8 were expressed but class I/b2m/calreticulin complexes (Sadasivan et al.,
expression was fully restored in the presence of human 1996). HLA-B27 can associate with TAP in 721.221 cells
tapasin. Pulse-chase studies of 721.220 transfectants (Solheim et al., 1997); however, it is known that class I
revealed that maturation and transport of B*2705 mole- molecules do not all associate equally well with the TAP
cules occurred in both tapasin-positive and -negative complex (Neisig et al., 1996). Therefore, we wondered
transfectants, but with slower kinetics in tapasin-nega- whether the spectrum in tapasin dependence of class
tive cells (data not shown). On the other hand, matura- I molecules reflected allelic variation in the ability of
tion and structural integrity of B*4402 molecules were class I molecules to associate directly with TAP.
very dependent on tapasin (data not shown) as observed Hence, we examined whether there were detectable
in mouse J26 cells. Thus, HLA class I molecules exhibit differences in the ability of B*2705 versus B*4402 to
a spectrum of dependence on tapasin for biochemical associate with TAP in the presence and absence of
tapasin. Equal numbers of cells were radiolabeled andmaturation and surface expression in human cells.
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Differential HLA Class I±Restricted Antigen
Presentation in the Absence of Tapasin:
A Spectrum of Tapasin Dependence
in Peptide Loading
Tapasin is known to be critical for the presentation of
specific viral peptides by certain HLA class I molecules
expressed by the tapasin-deficient 721.220 cell line (Ort-
mann et al., 1997). Nonetheless, the hierarchy of stable
expression of B*2705 . B8 .. B*4402 in 721.220 sug-
gested that presentation of peptide antigens might be
differentially impaired in the absence of tapasin. We
therefore compared the presentation of viral peptide
antigens by HLA-B*4402, B8, and B*2705 molecules ex-
Figure 4. Tapasin Expression Enhances the Association of Both pressed on 721.220 in the presence and absence of
HLA B*2705 and B*4402 Molecules with TAP
human tapasin. Transfected 721.220 targets were in-
Equal numbers of the indicated cells were labeled with [35S]methio- fected with recombinant vaccinia viruses expressing de-nine for 15 min and lysed in digitonin buffer. Immunoprecipitates
fined Epstein-Barr virus (EBV) antigens (Vacc.EBNA) andwere formed with mAb 148.3 (anti-TAP1), bound to protein A sepha-
cytotoxicity was measured after incubation with virus-rose beads and washed. Immune complexes were then dissociated
from the protein A±sepharose beads in SDS buffer and eluted pro- specific, HLA-restricted cytotoxic T lymphocytes (CTLs)
teins were reacted with mAb HC-10 (anti-HLA free heavy chains). (Figure 5).
The new immune complexes were separated by 10% SDS-PAGE As shown in Figure 5A, an EBV-specific B44-restricted
and autoradiographed after fluorography. The position of HLA class CTL clone did not lyse an untreated homozygous B*44021
I heavy chains (HC) is indicated by an arrowhead. Cell lines studied
lymphoblastoid cell line (LCL) (0.7%) but produced sig-were Jurkat (positive control), T2 (a TAP-negative human LCL; nega-
nificant lysis of 721.220.B*4402.tapasin (35%). Thesetive control), 721.220 (parental tapasin-negative LCL), 721.220.
Tapasin (721.220 transfectant expressing tapasin alone), 721.220. findings probably reflect the low constitutive level of
B*2705 (721.220 transfectant expressing HLA B*2705), 721.220.B*4402 presentation of endogenous EBNA4 by LCLs and the
(721.220 transfectant expressing HLA B*4402), 721.220.B*2705.Ta- increased efficiency of peptide loading resulting from
pasin (721.220 transfectant expressing HLA B*2705 plus tapasin), overexpression of the introduced tapasin gene. In con-
and 721.220.B*4402.Tapasin (721.220 transfectant expressing HLA
trast to the tapasin transfectants, 721.220. B*4402 tar-B*4402 plus tapasin).
gets lacking tapasin were not killed by SE2 even follow-
ing 12 hr infection with Vacc.EBNA4. The same duration
of Vacc.EBNA4 infection significantly enhanced lysis of
lysed in digitonin buffer. Sequential immunoprecipita- B*44021 LCL (0.7% to 58%) and of 721.220.B*4402.
tion was performed with a monoclonal antibody (mAb) to tapasin targets (35% to 53%). Importantly the 721.220.
the hTAP1 molecule, followed by dissociation of bound B*4402 cells lacking tapasin could be sensitized for lysis
immune complexes in sodium dodecyl sulfate (SDS) so- by pulsing with specific EBNA4 peptide. Thus, tapasin is
lution, and reprecipitation by mAb HC-10, which recog- critical to antigen presentation by B*4402, in agreement
nizes HLA-B class I free heavy chains but also cross- with observations made by Ortmann et al. (1997).
reacts with some free HLA-C heavy chains (Stam et al., In contrast to the profoundly impaired presentation
1986). As shown in Figure 4, anti-TAP immune precipi- of antigens by B*4402 in the absence of tapasin, HLA-B8
tates from the Jurkat cell line contained class I heavy molecules expressed in 721.220 did present the EBNA3
chains as expected. In contrast, class I heavy chains peptide QAKWRLQTL to the CTL clone LC15 under cer-
were not recovered in anti-TAP immunoprecipitates tain conditions (Figure 5B). Significantly, after 4 hr infec-
from either TAP-negative T2 cells or tapasin-negative tion with Vacc.EBNA3, 721.220.B8 targets lacking ta-
721.220 cells. Very low levels of TAP-associated class pasin were only poorly lysed (9%) compared with
I heavy chains were detected in 721.220.B*2705 and 721.220. B8.tapasin targets (56%). However, by 12 hr
721.220.B*4402 cells demonstrating that both B*2705 postinfection, 721.220.B8 targets were lysed (22%) at
and B*4402 associate poorly with TAP in the absence levels approaching those of 721.220.B8.tapasin targets
of tapasin. The weak band detected from 721.220 cells (52%). Importantly, LC15 lysed untreated HLA-B81 ho-
transfected with tapasin alone (721.220.tapasin) most mozygous LCL (26%) and untreated or control infected
probably reflects HLA-Cw1 heavy chains. However, 721.220.B8.tapasin targets (untreated, 47%; Vacc.TK2,
when 721.220. B*2705 and 721.220.B*4402 cells also 23%) but there was no significant lysis of untreated
expressed human tapasin (721.220.B*2705.tapasin and 721.220. B8 targets (3%). These findings indicate that
721.220.B*4402.tapasin), there was significantly en- although presentation of endogenous antigens by B8
hanced binding of HLA class I complexes to TAP consis- in the EBV-transformed targets is tapasin dependent
tent with a tapasin-mediated association of B*4402 and (untreated group, Figure 5B), B8 retains residual antigen
B*2705 with TAP. These data are consistent with the presentation function in the absence of tapasin as re-
observation that tapasin is required for efficient binding vealed by prolonged Vacc.EBNA3 infection.
of class I molecules to TAP and suggests that the high The antigen presentation function of HLA-B8 mole-
level of surface expression of B*2705 in the absence of cules in the absence of tapasin was examined by an-
human tapasin occurs despite the lack of direct binding other B8-restricted CTL clone, LC13, which recognizes
the EBNA3-derived epitope FLRGRAYGL (Figure 5C).of B*2705 to TAP.
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Figure 5. Allelic Polymorphism in the Efficiency of HLA Class I±Restricted Presentation of Specific Viral Peptides by Tapasin-Deficient Cells
Cytotoxicity assays were carried out on target cells incubated with EBV-specific CTL clones. Killing of the target cells was measured by
specific 51Cr release. (A) CTL clone SE2 was derived from a HLA-B*4403 positive donor but recognizes the EBNA4 peptide VEITPYKPTW when
presented by either HLA-B*4403 or B*4402, E:T ratio 2:1. (B) CTL clone LC15 recognizes the EBNA3 peptide QAKWRLQTL presented by HLA-
B8, E:T ratio 0.3:1. (C) CTL clone LC13 recognizes the FLRGRAYGL peptide of EBNA3 also presented by HLA-B8, E:T ratio 2:1. (D) CTL clone
BT7 recognizes the EBNA4 peptide HRCQAIRKK presented by HLA-B*2705, E:T ratio 1:1. Targets included untransfected 721.220 cells, HLA-B
homozygous LCLs,and 721.220 cells expressing the indicated HLA-B molecules with and without human tapasin. Targets were either untreated,
loaded with the indicated EBV peptide or infected with control (Vacc.TK2) or recombinant vaccinia virus expressing the indicated EBV antigen
(Vacc.EBNA3/4). Vaccinia infections proceeded for 4 or 12 hr before the assay. In (D), the CTL lysis assay against targets infected for 4 hr
with Vacc.EBNA4 was carried out separately from the other targets.
After 12 hr infection with Vacc.EBNA3, significant lysis viral peptides even in the absence of tapasin albeit with
reduced efficiency. Notably, when Vacc.EBNA4 infec-of 721.220.B8 targets was observed in the absence of
tapasin (42%) approaching that achieved by 721.220.B8. tion was allowed to proceed for 12 hr there was no
significant difference between lysis of tapasin-positivetapasin targets (77%).
Compared to the antigen presentation function of (73%) and tapasin-negative (72%) 721.220 cells ex-
pressing B*2705. In a separate experiment involving aHLA-B8, B*2705 molecules showed even greater inde-
pendence from tapasin in their antigen presentation 4 hr Vacc.EBNA4 infection, lysis of tapasin-negative
721.220.B*2705 targets approached half the levels ob-requirements (Figure 5D). Thus, the CTL clone BT7 in-
duced low but significant levels of lysis in 721.220. served in 721.220.B*2705.tapasin targets (Figure 5D).
Together, these data help define functional polymor-B*2705 targets even when the only source of EBNA4
antigen was that derived endogenously from the trans- phism in tapasin dependence for efficient peptide load-
ing of class I molecules. The differences in antigen pre-forming EBV. The level of lysis observed in 721.220.
B*2705 targets (16%) was lower than that in either sentation at 4 and 12 hr postinfection with Vacc.EBNA
proteins reveal a kinetic disturbance in antigen presen-B*27051 LCLs (22%) or 721.220. B*2705.tapasin targets
(26%) (untreated group, Figure 5D). This indicated that tation in the absence of tapasin. Accordingly, after a 4
hr vaccinia infection 721.220.B8 is lysed to 20% the levelB*2705 molecules were able to load and present specific
Tapasin and Antigen Presentation by HLA-B27
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of its tapasin-positive equivalent, whereas after a 12 hr
vaccinia infection the lysis of 721.220.B8 is nearly 50%
of that observed for 721.220.B8.tapasin. For B*2705
tapasin-negative targets the lysis 4 hr postinfection is
already half that of the tapasin-positive B*2705 targets
and by 12 hr postinfection there was no detectable
difference in the recognition of 721.220.B*2705 and
721.220.B*2705.tapasin targets. Prolongation of the du-
ration of Vacc.EBNA infection may therefore favor load-
ing of those HLA class I molecules that can persist in a
peptide-receptive state in the absence of tapasin.
Serologically Distinct HLA-B*2705 Molecules
Suggest That an Altered Peptide Display
Is Expressed in the Absence of Tapasin
The high level of thermostable HLA-B*2705 expressed
on the cell surface of 721.220 suggests peptide occu-
pancy of these molecules despite the absence of ta-
pasin. However, the presentation of specific viral pep-
tides by B*2705 was clearly impaired in the absence of
tapasineven though prolonged infectionwith Vacc.EBNA4
substantially restored antigen presentation. These find-
ings suggested that although there was some overlap
in the nature of the peptides captured by B*2705 in the
absence and presence of tapasin, it was also likely that
there were significant differences in the peptide reper-
toire selected by B*2705 molecules under these two
circumstances. To test this notion we examined the ex-
pression of peptide-dependent anti-HLA class I mAb
determinants on the surface of 721.220.B*2705 and
721.220.B*2705.tapasin. The expression of B*2705 was
essentially similar in tapasin-positive and -negative
transfectants stained with mAbs 116.5.28 (anti-Bw4)
(Figure 3), ME1 or HLA-ABCm3 (Figure 6A). These mAbs
are known to be peptide sensitive as reflected in their
reduced staining of B*2705 molecules expressed by the
TAP-deletion mutant T2 (Figure 6A). These data alone
suggest that the expression of peptide-loaded B*2705
molecules might be broadly similar in the presence and
Figure 6. An Altered Repertoire of Peptides Is Selected for Presen-
absence of tapasin. However, mAb B27M1 gave quite tation by HLA B*2705 Molecules Expressed in the Absence of Ta-
distinct patterns of staining in 721.220.B*2705 tapasin- pasin
positive and tapasin-negative cells. The peak channel (A) 721.220 cells expressing B*2705 in the presence (1) or absence
fluorescence staining with mAb B27M1 was 8-fold higher (2) of human tapasin and the TAP-deletion mutant T2 expressing
B*2705 were stained with the indicated HLA class I±specific mAbsin the tapasin-positive versus tapasin-negative cells.
by indirect immunofluorescence. Cells were cultured at 378C, andThis mAb is relatively specific for HLA-B*2705 and is
the filled histograms represent staining of untransfected 721.220 orknown to react with some but not all HLA-peptide com-
T2 cells.plexes (Wang et al., 1994). Therefore the higher levels
(B) B*2705 expressing 721.220 tranfectants with (721.220.B*2705.
of B27M1 staining in 721.220.B*2705.tapasin cells indi- tapasin) and without (721.220.B*2705) tapasin were stained by indi-
cates a significant difference in the repertoire of pep- rect immunofluorescence with the mAb HC-10, which recognized
free heavy-chain epitopes. Cell surface expression of free heavytides bound to B*2705 molecules in the presence versus
chain on 721.220.B*2705 was reexamined after overnight incubationthe absence of tapasin.
with either 10 mM of a B*2705-binding peptide HRCQAIRKK or irrele-
vant peptide. All cells were cultured at 378C. The filled histogram
indicates staining of untransfected 721.220 cells and 721.220 cellsB*2705 Molecules Expressed on the Surface
transfected with tapasin alone.of Tapasin-Negative Cells
Are Structurally Unstable
We considered that in the absence of tapasin, thealtered either premature dissociation from b2m or occupation by
extracellular ligands. To assess the structural integrity ofrepertoire of peptides presented by B*2705 may include
some peptides with lower binding affinity than those B*2705 complexes expressed in the absence of tapasin,
we compared the expression of free heavy chains onloaded through a tapasin-dependent pathway. Such
peptides would be liable to dissociate from B*2705 mol- the cell surfaces of 721.220.B*2705 and 721.220.B*2705.
tapasin transfectants with the mAb HC-10, which recog-ecules at a faster rate than peptides of higher binding
affinity thus rendering B*2705 complexes vulnerable to nized free class I heavy-chain epitopes (Stam et al.,
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1986) (Figure 6B). 721.220.B*2705 transfectants ex- been shown to restore surface expression and antigen
pressed considerably higher levels of free heavy-chain presentation of HLA class I molecules in 721.220 without
epitopes than 721.220.B*2705.tapasin transfectants, in- restoring the association of class I molecules with TAP
dicating the presence of surface membrane B*2705 (Lehner et al., 1998). This finding lends support to a role
complexes that had already dissociated or were in the for tapasin in stabilizing empty class I complexes in a
process of dissociating from b2m. Furthermore, the ex- peptide-receptive conformation. However, these poten-
pression of free B*2705 heavy chains could be specifi- tial functions of tapasin are not necessarily mutually
cally lowered by addition of exogenous B*2705-binding exclusive and indeed, tapasin also seems to increase
peptide but not by addition of irrelevant peptide. Protec- the expression of TAP presumably enhancing thesupply
tion of unstable B*2705 complexes was concentration of peptides for class I assembly (Lehner et al., 1998).
dependent (data not shown). Together these data sug- There is conflicting evidence on whether class I mole-
gest that not only do B*2705 complexes expressed in cules must all physically associate with TAP in order to
the absence of tapasin present an altered repertoire of assemble with peptides. Thus, HLA molecules vary in
peptides, but some of these complexes are also struc- the strength of TAP binding (Neisig et al., 1996) and
turally more unstable perhaps because of the very na- HLA-B8 captures peptides without associating with TAP
ture of peptides that they present. in the presence of soluble tapasin (Lehner et al., 1998).
In contrast, a mutation in the HLA-A2 a2 domain (T134K)
Discussion is associated with impaired TAP binding and antigen
presentation (Lewis et al., 1996; Peace-Brewer et al.,
Coexpression of human tapasin but not human TAP 1996). The structural basis of this observation is not
fully restored the intracellular maturation and surface understood, and indeed the precise sites of interaction
expression of B*4402 complexes in murine cells. Since between TAP and class I molecules and the nature of
mouse cells endogenously express murine tapasin, these interactions (direct or indirect) remain unclear
these findings imply that amino acid sequence differ- (Carreno et al., 1995; Suh et al., 1996). The novelty of
ences between human and murine tapasin account for our observations is that they demonstrate intact peptide
this molecular incompatibility. In contrast, B*2705 was loading of B*2705 and antigen presentation in the ab-
expressed at high surface levels in mouse cells and sence of binding to either tapasin or TAP. In addition
in tapasin-negative human cell line 721.220, making it
the data imply that allelic variation in HLA class I±TAP
unclear whether B*2705 expression is tapasin indepen-
binding in the presence of tapasin (Neisig et al., 1996)
dent in mouse cells as for 721.220, or whether B*2705
may be secondary to differential class I interaction with
interacts productively with murine tapasin. These find-
bridging chaperones such as calreticulin and/or tapasin.
ings suggest that varying degrees of compatibility be-
We propose that in the absence of tapasin, empty
tween human class I/b2m complexes and components B*2705/b2m complexes remain stable for sufficient timeof themouse antigen presentation machinery,especially
to acquire ER peptides without the need to interact di-tapasin, might explain some of the allelic variation in
rectly with TAP. By comparison, empty B*4402/b2mthe assembly of different HLA class I molecules in murine
complexes appear to be unstable in the absence ofcells. Accordingly, the use of HLA-transgenic mice as
tapasin and so these molecules maybe degraded beforemodels of HLA-restricted immune responses warrants
they can be loaded with peptides. However, ªemptyºcareful consideration of whether the peptide repertoire
B*2705 molecules still require peptides for their ultimateselected by HLA class I molecules is physiological in
stabilization and transport to the cell surface explainingthese systems.
the low expression of these molecules on the surfaceSignificantly, B*2705 molecules expressed in the ab-
of theTAP-negative T2 cell line. The putative differencessence of tapasin remained functionally capable of pre-
in the stability of empty B*2705/b2m versus emptysenting endogenous antigens. B8 molecules also pre-
B*4402/b2m might result from differential association ofsented EBV antigens in the absence of tapasin but only
the two heavy chains with b2m or chaperone moleculesafter the supply of peptides had been boosted by pro-
like calreticulin, BiP and invariant chain (NoÈ ûner andlonged infection with recombinant Vacc.EBNA3 virus.
Parham, 1995; Vigna et al., 1996; Elliott, 1997).Notably, CTL recognition of Vacc.EBNA-infected cells
It is interesting to speculate that the spectrum of ta-was not the result of endogenous peptide transfer be-
pasin dependence as shown by B*2705, B8 and B*4402tween infected cells since lysis of HLA-expressing TAP-
may have evolved in response to evolutionary pressuresdeficient targets has never been observed by us under
exerted by microbial agents. Conceivably, some micro-these same conditions. Thus, although tapasin is clearly
bial agents may have developed inhibitors against ta-critical for efficient antigen presentation, the require-
pasin as a ploy to thwart the antigen presentation pro-ment for tapasin is not absolute for all HLA molecules
cess and evade development of specific immunity (Fruhand may not be absolute for all antigenic peptides.
et al., 1995; Hill et al., 1995; Ahn et al., 1997; Hengel etTapasin mediates the association of multimeric empty
al., 1997; Lehner et al., 1997). The flexibility offered byclass I/b2m/calreticulin complexes with TAP (Sadasivan
tapasin independence might permit certain class I mole-et al., 1996; Ortmann et al., 1997), thus enhancing pep-
cules to continue presenting viral antigens in the facetide loading of class I molecules. However, it is also
of specific interference of tapasin function.possible that tapasin may function to stabilize empty
Although the expression level of the B*2705 moleculeclass I complexes in a peptide-receptive conformation
in the absence of tapasin compares well to that whensuitable for peptide sampling analogous to the role sug-
coexpressed with tapasin, these B*2705 molecules maygested for HLA-DM in class II±restricted antigen presen-
tation (Denzin et al., 1996). Soluble tapasin has recently not display exactly the same repertoire of endogenous
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cellular peptides. One possibility is that signal sequence ankylosing spondylitis and anterior uveitis is well estab-
lished (Khan, 1995). Reactive polyarthritis and Reiter'speptides play an exaggerated role in the peptide reper-
toire presented by B*2705 in the absence of tapasin. syndrome frequently follow infections with intracellular
microorganisms such as enteric bacteria and chlamydia.However this has not been reported in elution studies
of B*2705-bound peptides (Jardetzky et al., 1991) and Accordingly, it has been speculated that HLA-B27 might
present a conserved microbial peptide that triggersB*2705 is TAP dependent as shown by poor surface
expression in the T2 cell line. Another possibility is that cross-reactive autoimmune T cell responses resulting
in disease (Benjamin and Parham, 1990; Hermann etonly a subset of TAP-dependent peptides are selected
for presentation in the absence of tapasin. Presumably, al., 1993). However, evidence unequivocally implicating
microbial peptides is lacking. A direct role for the HLA-in the loading of B*2705 complexes without tapasin,
peptides of higher abundance and of longer half-life B27 molecule in these diseases is supported by the
findings that HLA-B27 transgenic rodents develop manywould be favoured over peptides of lower abundance
and of shorter half-life. It is interesting to note that pep- of the features of human inflammatory spondyloarthrop-
athy (Hammer et al., 1990). In those HLA-B27 transgenictides considerably longer than the conventional class
I±bound peptides have been eluted from a subset of rodent models lacking b2m, nonfunctional forms of HLA-
B27 may also produce disease (Khare et al., 1995). ThisB*2705 complexes expressed in cellscontaining tapasin
(Urban et al., 1994). Tapasin may play a quality control together with the observation that transfer of CD41 T
cells from arthritic transgenic animals into irradiatedor peptide editing function in class I peptide assembly
analogous to the function of HLA-DM in class II peptide nontransgenic animals can induce disease (Breban et
al., 1996) raises the possibility that HLA-B27 can beloading (Kropshofer et al., 1996; Weber et al., 1996),
so that the peptide repertoire may be affected by its processed as a nominal antigen and then presented
by class II molecules to CD41 T cells that mediate theexpression.
Given that HLA-B*2705 is potentially tapasin indepen- development of disease (Parham, 1996). Our data sug-
gest that B*2705 molecules may present weakly bounddent, what could be the physiological significance of a
tapasin-independent pathway in antigen presentation? peptides through a tapasin-independent pathway thus
rendering them relatively unstable, as reflected in theTwo pieces of evidence indicate that B*2705 uses a
tapasin-dependent pathway in normal cells. First, the increase in surface expression of free heavy chains.
These unstable molecules would be highly susceptiblekinetics of viral antigen presentation are more rapid in
tapasin-positive than in tapasin-negative cells (Figure to endosomal degradation allowing peptides derived
from HLA-B27 toassemble with class II molecules. Alter-5D, compare 4 hr versus 12 hr Vacc.EBNA4 infection).
Second, the peptide repertoires presented by tapasin- natively, unstable HLA-B27 molecules might be highly
receptive to occupation by extracellular ligands as pre-positive and -negative cells are different. Therefore, we
believe that a tapasin-dependent pathway is active in viously shown for newly synthesized B27 molecules ex-
pressed by living cells (Benjamin et al., 1991). Thesenormal, B*27051 cells. Nonetheless, the capacity of
B*2705 to present viral peptide antigens in the absence properties of B27 could be explained by the presence
of a tapasin-independent pathway that creates a poolof tapasin indicates that the tapasin-independent path-
way can function in physiological infection and would of B27 molecules highly receptive to loading with exoge-
nous ligands. It is also possible that because of species-permit continued antigen presentation under the likely
constraint of tapasin interference by certain pathogens. incompatible usage of tapasin, the tapasin-independent
pathway of antigen presentation might be active in HLA-There is also some indirect evidence that tapasin-
independent antigen presentation by B*2705 functions B27 transgenic rodents that develop features of anky-
losing spondyloarthropathy. Accordingly, our observa-despite the presence of tapasin. A study by Tussey and
colleagues reported that the HLA-B8 molecule failed tions might unify a number of observations that rely on
the novel finding of a tapasin-independent pathway ofto present the 380ELRSRYWAI388 epitope from influ-
enza-A nucleoprotein when coexpressed specifically antigen presentation by HLA-B27.
It is intriguing to speculate that disrupted tapasinwith HLA-B*2702 but not other HLA-B alleles, even
though B8 presented other nucleoprotein epitopes un- function might shift the antigen presentation pathway
of HLA-B27 molecules leading to the appearance of ander the same conditions (Tussey et al., 1995). Accord-
ingly, B8 and B*2702 were observed to share overlap- altered self-peptide repertoire and potential sensitivity
ping epitopes from the Flu NP, namely NP 380±388 for of HLA-B27 to exogenous ligands. It will be important
B8 and NP 381±388 for B*2702. Having established that to determine whether any of the known microbial trig-
B8 and B*2702 bound their respective NP epitopes com- gers of spondyloarthritis interfere with the function of
parably well, and having excluded preferential genera- tapasin or related molecules.
tion or transport of the B*2702-restricted epitope, these
authors argued that competition between B*2702 and Experimental Procedures
B8 for limiting amounts of a common peptide fragment
Cell Lines and Antibodiesled to suboptimal loading of B8 molecules. Since B*2702
J26 was derived from murine L cells by transfection with the humanis closely related to B*2705, the coexistence of a ta-
b2m gene (Kavathas and Herzenberg, 1983); Jurkat is a human Tpasin-independent pathway of antigen presentation by
cell leukaemic line (Gillis and Watson, 1980); 721.220 is derived
B*2705 may well explain the competitive advantage of from mutagenesis of a human LCL in which the HLA-A, HLA-B, and
B*2702 over B8 in capturing limiting amounts of an over- tapasin genes have been deleted but HLA-C remains intact on one
lapping peptide even in the presence of tapasin. chromosome (Greenwood et al., 1994); T2.B*2705 is a transfected
derivative of the TAP-negative T2 cell line (Salter et al., 1985). CellsThe association of HLA-B27 with reactive arthritis,
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were grown in either RPMI-1640 or Dulbecco's modified Eagle's points, 5 3 106 cells were collected, washed in cold phosphate-
buffered saline, and lysed in Nonidet P-40 [NP-40] buffer in TBSmedium supplemented with 10% fetal calf serum (CSL, Australia),
2 mM glutamine, and antibiotics. EBV-specific CTL clones LC15, (0.5% NP-40, 10 mM Tris [pH 7.4], 150 mM NaCl) containing PMSF,
leupeptin, and aprotinin for 30 min at 48C. After cell nuclei had beenLC13, BT7, and SE2 were generated from EBV-seropositive donors
LC (HLA-B*0801), BT (HLA-B*2705), and SE (HLA-B*4403) respec- centrifuged, cell lysates were precleared with protein A±sepharose
(Pharmacia Biotech, Sweden) prior to immunoprecipitation withtively as described (Burrows et al., 1992, 1994; Rickinson and Moss,
1997). LCLs were established by transformation of peripheral B cells mAb W6/32. Thereafter, protein A±sepharose beads were added to
bind immune complexes. The beads were washed once in 450 mMwith A-type EBV.
W6/32 (Parham et al., 1979) is a conformation-dependent mouse NaCl solution containing 5 mM EDTA, 50 mM Tris (pH 7.4), 0.05%
NP-40, and 0.25% gelatin and once in 10 mM Tris buffer. BeadsmAb specific for all HLA class I molecules; mouse mAbs 116.5.28
and 126.39 recognize the HLA-Bw4 and -Bw6 epitopes respectively were boiled in 50 ml of 1% SDS solution in 0.1 M Tris (pH 8.0) and
1% 2-mercaptoethanol for 5 min. Nine volumes of 0.15 mM sodium(Saxon Europe, Suffolk, UK); mousemAbs 148.3 and 429.3 recognize
the hTAP1 and hTAP2 molecules respectively (Meyer et al., 1994); citrate (pH 5.5) was added to the supernatant, and samples were
divided; one half was treated with 5 mU of endoglycosidase-HHC-10 is a mouse mAb that recognizes free HLA class I heavy chains
(Stam et al., 1986); mouse mAb ME1 (Ellis et al., 1982) recognizes (Boehringer Mannheim, Germany) and the other half was untreated.
After incubation overnight at 378C, equal volumes of 30% trichloro-an epitope of HLA-B shared by HLA-B27, B7 and Bw22; mouse
mAb HLA-ABC-m3 (Trapani et al., 1983) recognizes a determinant acetic acid were added to precipitate proteins. After extensivewash-
ing in cold acetone, proteins were separated by SDS polyacrylamideof HLA-B shared by HLA-B27 and B7 molecules; and mouse mAb
B27M1 (Grumet et al., 1981) recognizes a peptide dependent confor- gel electrophoresis (PAGE) in a 10% gel. The gel was fixed, ampli-
fied, dried, and exposed to radiographic film for 5 days. For sequen-mation of HLA-B27 and -B7.
tial immunoprecipitation, cells that had been labeled with [35S]methi-
onine for 15 min were lysed in 0.5% digitonin buffer in TBS for 30Gene Constructs and DNA-Mediated Gene Transfer
min at 48C. After cell nuclei had been centrifuged, samples wereGenomic HLA-B*4402 was subcloned from pSVneo.B*4402 (Kapasi
precleared overnight with normal rabbit serum and protein A±sepha-and Inman, 1992) into the puc13 vector. Genomic HLA-B*2705 was
rose. Primary immunoprecipitation was carried out with anti-hTAP1also contained in puc13 vector (Weiss et al., 1985). B*4402 cDNA
mAb 148.3 before protein A±sepharose beads were added. Beadswas derived from B*44021 B LCL mRNA by RT-PCR using the 59
were washed twice in 0.1% digitonin buffer containing 450 mMprimer GCCCGTCGACGGACTCAGAATCTCCCCAGACGCCGAG and
NaCl, 10 mM Tris (pH 7.4) and once in 10 mM Tris buffer. Immunethe 39 primer CCGCAAGCTTCTGGGGAGGAAACACAGGTCAGCAT
complexes were dissociated by incubation in 50 ml of 0.2% SDS inGGGAAC (Zemmour et al., 1992). The PCR fragment was inserted
TNE (50 mM Tris, 150 mM NaCl, and 5 mM EDTA [pH 7.4]) for 1 hrinto the hCMV-IE vector (Thomsen et al., 1984). HLA-B8 cDNA (Tus-
at 378C. Supernatants were equilibrated with 9 volumes of 1% NP-sey et al., 1995) was also inserted into hCMV-IE. cDNAs encoding
40 and 0.5% nonanoyl-N-methyl-glucamide (Sigma, St. Louis, MO)hTAP1 and hTAP2 were contained in pHbApr-1-neo vector (Cerun-
in TNE. Secondary immunoprecipitation was carried out with mAbdolo et al., 1995). The human tapasin cDNA was cloned into either
HC-10; protein A±sepharose beads were added; and the beads werepMCFR.puro or pMCFR.neo (Ortmann et al., 1997). Mouse J26 cells
washed twice with 0.5% NP-40 in TNE. Beads were boiled in SDSwere transfected by the calcium phosphate±DNA precipitation
sample buffer, proteins separated by SDS-PAGE in a 10% gel, andmethod (Sambrook et al., 1989) with either puc13. B*4402, puc13.
the gel therafter treated as described above.B*2705, hCMV-IE.B*4402, or hCMV-IE.B8 and the selectable marker
gene pSVneo. In other transfections, pHbApr.neo.hTAP1, pHbApr.
neo.hTAP2, or pMCFR.puro.hTapasinwere cotransfectedwith these Cytotoxicity Assay
Target cells were tested for lysis in duplicate in the standard 5 hrHLA genes. Transfectants were selected with either G418 0.5 mg/
ml or puromycin 4 mg/ml. Jurkat was transfected with linearized chromium release assay. Where synthetic peptide was used, it was
added to target cells during chromium labeling (10 mM for 1 hr), andpSVneo.B*4402 plasmid by electroporation at 220V and 960 mF.
The same electroporation settings were used to transfect 721.220 unbound peptide was washed off target cells before addition of
effector CTLs. Recombinant vaccinia virus was added to some tar-with linearized puc13.B*4402, puc13.B*2705, or hCMV-IE.B8 with
pSVneo or pMCFR.neo.hTapasin. Jurkat transfectants were se- get cells using a multiplicity of infection of 10:1 for 4 or 12 hr at
378C as described earlier (Khanna et al., 1991) before target cellslected with G418 2.0 mg/ml initially. 721.220 transfectants were
selected with G418 0.6 mg/ml. Where possible, positive transfec- were washed and labeled with chromium. A top-count microplate
b scintillation counter (Packard Instrument, Meriden, CT) was usedtants were sorted for peak channel expression of HLA molecules
using magnetic beads that had been coated with an appropriate to measure 51Cr levels in assay supernatant samples. The mean
spontaneous lysis for target cells in culture medium was less thanmAb. In uncloned pools of transfectants there was no significant
difference detected in the expression of HLA-B*4402 obtained from 20%, and the variation from the mean specific lysis was less than
10%. Peptides were synthesized by Chiron Mimotopes (Chiron Cor-the genomic construct versus the cDNA expression plasmid (data
not shown). poration) using pin technology (Valerio et al., 1991).
Vaccinia Virus RecombinantsFlow Cytometry
Cell surface staining for HLA expression was performed by indirect Recombinant vaccinia constructs for the EBNA3 and EBNA4 genes
have been previously described (Khanna et al., 1991; Murray et al.,immunofluorescence on cells cultured overnight at either 378C or
268C as indicated. mAbs W6/32, 116.5.28, 126.39, ME1, HLA- 1992). The EBV sequences were derived form the B95.8 strain of
virus. Both constructs have the potential to encode the relevant fullABCm3, B27M1, or HC-10 were used as primary antibodies followed
by goat anti-mouse antiserum conjugated to fluorescein isothiocya- length EBV protein and utilizing the authentic start and stop codons.
Both constructs are under the control of the vaccinia virus P7.5nate (Silenus, Australia). 104 cells were analyzed for each histogram
using a FACS Analyzer (Becton Dickinson, CA) with logarithmic gain. promoter. A vaccinia virus construct made from insertion of the
pSC11 vector alone and negative for thymidine kinase (Vacc.TK2)For the experiment shown in Figure 6B, cell lines were incubated
overnight at 378C and where indicated either 10 mM of a B*2705- was used as control.
binding peptide HRCQAIRKK (Rickinson and Moss, 1997) or 10 mM
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